Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USTR names Brazil, India and Turkey on "priority watch list" due to pharmaceutical patent concerns.

Executive Summary

USTR SPECIAL 301 ACTIONS NAME BRAZIL, INDIA AND TURKEY among eight "priority watch list" countries. The three countries are among five that the Pharmaceutical Research & Manufacturers of America wanted designated as "priority foreign countries" under the U.S. Trade Representative intellectual property sanction system. The two other countries identified by PhRMA -- Argentina and Singapore -- were classified as "watch list" countries by USTR. The European Union, Greece, Japan, Korea, and Saudi Arabia were also identified as being on the priority watch list; 22 other countries were placed on the watch list.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel